Skip to main content

Zerit generic gets FDA approval


PITTSBURGH The Food and Drug Administration has approved a generic version of Bristol-Myers Squibb's Zerit by Mylan's Indian subsidiary, Mylan announced Tuesday.

The FDA approved Matrix Labs? stavudine capsules USP in 15 mg, 20 mg, 30 mg and 40 mg strengths. The drug is an antiretroviral used to treat HIV infection in combination with other antiretroviral drugs. The branded version of the drug had sales of about $54 million in the 12 months ending Sept. 30, according to IMS Health data.

Mylan owns a 71.5% stake in Matrix.

This ad will auto-close in 10 seconds